Please enable Javascript
Scott Kopetz, MD, PhD
Articles by Scott Kopetz, MD, PhD
BREAKWATER: Encorafenib, Cetuximab, and Chemotherapy for Mutant Metastatic Colorectal Cancer
Scott Kopetz, MD, PhD
Colorectal Cancer
|
February 3, 2025
Dr. Kopetz elaborates on the key efficacy and safety findings, including how they compare to current standard treatments.
View More